Robust, Scalable Manufacturing: N-Linked Glycan Analysis For Complex Glycoproteins
Source: AGC Biologics

The client had an established cell line and a bench-scale manufacturing process for a complex glycoprotein that produced high quality material but had a low yield and was not scalable. With plans to move into clinical development, the challenge for AGC Biologics was to develop a robust, scalable manufacturing process for this molecule, including defining the glycosylation parameters, implementing AGC Biologics’ glycan assay, and meeting the client’s production level requirements.
Learn how the client achieved a robust process for producing high-quality material at scale.
VIEW THE CASE STUDY!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Cell & Gene? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
AGC Biologics
This website uses cookies to ensure you get the best experience on our website. Learn more